Which Weight Loss Treatment Offers Better Value for UK Patients?
Is Wegovy or Mounjaro Better for Weight Loss: Understanding Your Best Value Options
When evaluating whether Wegovy or Mounjaro is better for weight loss, cost-effectiveness plays a crucial role alongside clinical considerations. Wegovy (semaglutide) operates as a GLP-1 receptor agonist, whilst Mounjaro (tirzepatide) functions as a dual GIP and GLP-1 receptor agonist. Both prescription-only medicines require careful dose escalation and ongoing clinical supervision, but their pricing structures and practical considerations differ significantly across UK pharmacies.
EverydayMeds has positioned itself as the UK's most competitive provider for Wegovy, with transparent pricing that includes consultation, prescriber review, and next-day delivery. Our approach eliminates hidden fees and unexpected costs, allowing patients to budget effectively for their weight management journey. Unlike other providers who may charge separately for consultations or delivery, our comprehensive pricing model ensures you know exactly what you'll pay from the outset.
Wegovy vs Mounjaro Weight Loss Pricing: Complete UK Cost Breakdown
Wegovy pricing at EverydayMeds starts from £79.99 for the 0.25mg starter dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive rates. Our bundle options, such as the Intro Trio at £299.99, provide convenient multi-month supplies without the hassle of monthly reordering.
Mounjaro, whilst effective, typically commands higher pricing across most UK providers due to its newer market position and dual-agonist mechanism. When comparing value propositions, consider not just the medication cost but also the complete service package, storage requirements, and long-term treatment sustainability. EverydayMeds' pricing transparency extends to our clear escalation pathway, helping patients understand their total treatment investment from starter doses through maintenance therapy.
Clinical Evidence: Wegovy vs Mounjaro for Weight Loss Effectiveness
In the landmark STEP 1 clinical trial, patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme demonstrated consistent results across diverse patient populations, with STEP 2 showing clinically studied weight loss in patients with type 2 diabetes and STEP 3 achieving 16% with intensive behavioural therapy support.
Mounjaro's SURMOUNT trials have shown promising results, though direct comparison between trials isn't methodologically sound due to different study designs, patient populations, and endpoints. Both medications require administration alongside a reduced-calorie diet and increased physical activity, and individual responses may vary considerably based on adherence, lifestyle factors, and metabolic characteristics.
How Wegovy Works: Understanding the Weight Loss Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of a naturally occurring hormone called glucagon-like peptide-1. This hormone is normally released by your intestines after eating and signals to your brain that you're satisfied, reducing appetite and promoting feelings of fullness. By activating GLP-1 receptors in the brain's appetite control centres, Wegovy may help reduce food cravings and make it easier to stick to smaller portion sizes. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satiety. This multi-faceted approach addresses several biological mechanisms involved in weight regulation, potentially making it easier to maintain the caloric deficit necessary for weight loss.
Streamlined Ordering: Is Wegovy or Mounjaro Better for Weight Loss Access?
EverydayMeds has revolutionised access to weight management treatments through our efficient three-step process. The initial clinical assessment takes approximately three minutes to complete online, covering medical history, current medications, and weight management goals. Our qualified prescribers review applications within three working days as standard, with express 24-hour review available for urgent cases. Once approved, medications are dispatched via next-day delivery using specialised cold-chain transport to maintain the required temperature throughout transit. This streamlined approach eliminates the traditional barriers of multiple GP appointments and long waiting times often associated with weight management services.
Storage and Practical Considerations for Long-Term Treatment
Wegovy offers a significant practical advantage with its storage flexibility, remaining stable at room temperature for up to six weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications must be stored in the fridge at 2-8°C before first use, but Wegovy's extended room temperature stability makes it more convenient for travel or temporary storage situations. The FlexTouch pen delivery system is pre-filled and disposable, requiring no mixing or special preparation. Dose escalation follows a mandatory schedule over 16 weeks, starting with 0.25mg weekly and increasing gradually to the 2.4mg maintenance dose. This systematic approach helps minimise gastrointestinal side effects whilst optimising therapeutic effectiveness.
Why Choose EverydayMeds for Wegovy vs Mounjaro Weight Loss Treatment
Our competitive advantage extends beyond pricing to encompass comprehensive patient support and medication continuity assurance. EverydayMeds maintains robust stock levels and direct manufacturer relationships, reducing the risk of treatment interruptions that can compromise weight loss progress. Our clinical team, operating under GPhC registration #9012878, provides ongoing support throughout your treatment journey, not just at the point of initial prescription.
The question of whether Wegovy or Mounjaro is better for weight loss ultimately depends on individual clinical factors, tolerance profiles, and practical considerations. Both medications are available through EverydayMeds, and our prescribers can help determine which option aligns best with your specific circumstances, medical history, and treatment goals.
Start Your Weight Management Journey Today
Beginning your weight loss treatment with EverydayMeds means accessing the UK's most competitive Wegovy pricing whilst maintaining the highest standards of pharmaceutical care. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to unlock our special pricing structure. Our comprehensive service includes the initial clinical assessment, prescriber review, genuine medication supply, and next-day cold-chain delivery, all within our transparent pricing model. Visit our Wegovy collection at https://everydaymeds.co.uk/collections/wegovy to begin your three-minute assessment today. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which is right for your weight management goals.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
